九安医疗
(002432)
| 流通市值：246.00亿 | | | 总市值：262.18亿 |
| 流通股本：4.37亿 | | | 总股本：4.66亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,018,379,739.8 | 2,460,352,643.79 | 2,973,738,293.77 | 3,326,370,969.22 |
| 结算备付金 | 0 | - | - | 0 |
| 拆出资金 | 0 | - | - | 0 |
| 交易性金融资产 | 7,040,323,514.94 | 6,806,826,929 | 5,415,174,207.32 | 7,356,661,222.68 |
| 衍生金融资产 | 0 | - | - | 0 |
| 应收票据及应收账款 | 74,010,041.72 | 64,987,024.89 | 45,001,256.8 | 48,356,305.34 |
| 其中：应收票据 | 3,123,294.17 | 909,607.36 | 549,329.72 | 449,069.52 |
| 应收账款 | 70,886,747.55 | 64,077,417.53 | 44,451,927.08 | 47,907,235.82 |
| 应收款项融资 | 0 | - | - | 0 |
| 预付款项 | 49,061,213.34 | 30,029,558.98 | 46,904,751.77 | 29,759,463.05 |
| 应收保费 | 0 | - | - | 0 |
| 应收分保账款 | 0 | - | - | 0 |
| 应收分保合同准备金 | 0 | - | - | 0 |
| 其他应收款合计 | 45,706,222.41 | 39,249,944.79 | 63,340,422.64 | 54,882,541.16 |
| 其中:应收利息 | 0 | - | - | 0 |
| 应收股利 | 1,270,956.74 | 647,561.85 | 4,232,487.1 | 6,445,442.28 |
| 买入返售金融资产 | 0 | - | - | 0 |
| 存货 | 221,173,218.77 | 212,133,684.81 | 203,405,224.94 | 204,231,499.69 |
| 合同资产 | 0 | - | - | 0 |
| 一年内到期的非流动资产 | 0 | 0 | 4,606,531,071.27 | 891,292,815.78 |
| 其他流动资产 | 32,934,493.56 | 23,229,761.81 | 27,790,392.93 | 24,133,183.19 |
| 流动资产合计 | 9,481,588,444.54 | 9,636,809,548.07 | 13,381,885,621.44 | 11,935,688,000.11 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | - | 0 |
| 债权投资 | 0 | 0 | 0 | 1,627,239,102.87 |
| 其他债权投资 | 0 | - | - | 0 |
| 长期应收款 | 0 | - | - | 0 |
| 长期股权投资 | 0 | 0 | 910,000 | 0 |
| 其他权益工具投资 | 0 | 382,881,541.6 | 571,253,604.6 | 723,100,138.57 |
| 其他非流动金融资产 | 26,513,349,510.63 | 22,367,537,030.66 | 14,844,743,454.2 | 13,725,486,518.9 |
| 投资性房地产 | 0 | - | - | 0 |
| 固定资产 | 459,158,262.69 | 464,269,410.49 | 469,801,226.91 | 480,383,435.3 |
| 在建工程 | 22,207,692.15 | 22,686,079.66 | 24,377,535.29 | 19,209,311.03 |
| 生产性生物资产 | 0 | - | - | 0 |
| 油气资产 | 0 | - | - | 0 |
| 使用权资产 | 29,250,104.21 | 30,560,453.44 | 38,307,559.94 | 48,088,788.87 |
| 无形资产 | 164,122,598.12 | 168,112,277.89 | 172,068,650.37 | 79,506,824.05 |
| 开发支出 | 10,432,536.46 | 10,253,970.66 | 10,177,383.49 | 9,975,088.2 |
| 商誉 | 0 | - | - | 0 |
| 长期待摊费用 | 13,293,895.01 | 15,541,999.65 | 16,845,671.95 | 20,337,388.34 |
| 递延所得税资产 | 214,391,992.63 | 197,088,935.93 | 235,011,831.11 | 233,529,333.97 |
| 其他非流动资产 | 209,392,363.66 | 454,718,522.12 | 142,304,694.08 | 408,313,070.67 |
| 非流动资产合计 | 27,635,598,955.56 | 24,113,650,222.1 | 16,525,801,611.94 | 17,375,169,000.77 |
| 资产总计 | 37,117,187,400.1 | 33,750,459,770.17 | 29,907,687,233.38 | 29,310,857,000.88 |
| 流动负债: | | | | |
| 短期借款 | 6,026,162,882.68 | 4,864,347,585.43 | 2,697,200,857.96 | 2,638,094,467.26 |
| 向中央银行借款 | 0 | - | - | 0 |
| 吸收存款及同业存放 | 0 | - | - | 0 |
| 拆入资金 | 0 | - | - | 0 |
| 交易性金融负债 | 0 | - | - | 0 |
| 衍生金融负债 | 0 | - | - | 0 |
| 应付票据及应付账款 | 59,181,735.66 | 63,078,703.46 | 45,374,138.81 | 62,644,959.77 |
| 其中：应付票据 | 0 | - | - | 0 |
| 应付账款 | 59,181,735.66 | 63,078,703.46 | 45,374,138.81 | 62,644,959.77 |
| 预收款项 | 0 | 0 | - | 0 |
| 合同负债 | 82,309,090.87 | 79,808,435.46 | 69,252,439.77 | 100,547,704.54 |
| 卖出回购金融资产款 | 0 | - | - | 0 |
| 应付手续费及佣金 | 0 | - | - | 0 |
| 应付职工薪酬 | 57,819,827.42 | 45,352,207.12 | 40,626,258.47 | 78,413,195.08 |
| 应交税费 | 6,097,924.45 | 4,030,929.3 | 5,886,461.99 | 33,921,226.34 |
| 其他应付款合计 | 15,564,723.51 | 235,574,699.66 | 13,557,729.85 | 30,275,860.73 |
| 其中:应付利息 | 0 | - | - | 0 |
| 应付股利 | 0 | 221,104,110.15 | - | 0 |
| 应付分保账款 | 0 | - | - | 0 |
| 保险合同准备金 | 0 | - | - | 0 |
| 代理买卖证券款 | 0 | - | - | 0 |
| 代理承销证券款 | 0 | - | - | 0 |
| 一年内到期的非流动负债 | 586,229,991.53 | 1,650,836,747.01 | 1,687,969,646.2 | 1,565,388,573.39 |
| 其他流动负债 | 464,458.42 | 319,154.35 | 425,624.37 | 388,526.15 |
| 流动负债合计 | 6,833,830,634.54 | 6,943,348,461.79 | 4,560,293,157.42 | 4,509,674,513.26 |
| 非流动负债: | | | | |
| 长期借款 | 972,500,000 | 976,000,000 | 1,327,000,000 | 1,451,500,000 |
| 应付债券 | 1,549,849,896.34 | 783,944,808.74 | 780,373,117.79 | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 租赁负债 | 17,464,969.37 | 17,874,167.65 | 21,801,920.88 | 26,909,075.45 |
| 长期应付款 | 0 | - | - | 0 |
| 长期应付职工薪酬 | 0 | - | - | 0 |
| 预计负债 | 0 | - | - | 0 |
| 递延收益 | 7,230,361.22 | 7,801,421.23 | 8,372,481.24 | 8,943,541.25 |
| 递延所得税负债 | 2,114,294,075.83 | 1,688,812,832.6 | 1,384,498,504.87 | 1,278,916,299.08 |
| 其他非流动负债 | 0 | - | - | 0 |
| 非流动负债合计 | 4,661,339,302.76 | 3,474,433,230.22 | 3,522,046,024.78 | 2,766,268,915.78 |
| 负债合计 | 11,495,169,937.3 | 10,417,781,692.01 | 8,082,339,182.2 | 7,275,943,429.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 466,244,320 | 466,040,570 | 465,111,650 | 464,938,540 |
| 其他权益工具 | 0 | - | - | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 资本公积 | 1,530,347,681.64 | 1,335,209,654.3 | 1,316,580,764.01 | 1,317,118,220.32 |
| 减:库存股 | 1,495,340,050.66 | 1,661,554,338.68 | 1,661,554,338.68 | 1,661,554,338.68 |
| 其他综合收益 | -328,168,830.68 | 96,064,432.52 | 676,909,625.85 | 1,184,760,922.26 |
| 专项储备 | 0 | - | - | 0 |
| 盈余公积 | 232,469,270 | 232,469,270 | 232,469,270 | 232,469,270 |
| 一般风险准备 | 0 | - | - | 0 |
| 未分配利润 | 25,057,995,317.97 | 22,672,622,104.94 | 20,587,959,672.85 | 20,294,426,420.35 |
| 归属于母公司股东权益合计 | 25,463,547,708.27 | 23,140,851,693.08 | 21,617,476,644.03 | 21,832,159,034.25 |
| 少数股东权益 | 158,469,754.53 | 191,826,385.08 | 207,871,407.15 | 202,754,537.59 |
| 股东权益合计 | 25,622,017,462.8 | 23,332,678,078.16 | 21,825,348,051.18 | 22,034,913,571.84 |
| 负债和股东权益合计 | 37,117,187,400.1 | 33,750,459,770.17 | 29,907,687,233.38 | 29,310,857,000.88 |
| 公告日期 | 2026-10-30 | 2026-08-25 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |